Oushod Sheba

Oushod Sheba

All category

ALFUMAX-ER

UNIMED UNIHEALTH


TABLET EXTENDED RELEASE)
10 MG

10

Generic Information

Generic name

ALFUZOSIN HYDROCHLORIDE

Indications

Alfuzosin is used for the treatment of functional symptoms of Benign Prostatic Hyperplasia (BPH). It is also used as a short term treatment of acute urinary retention (AUR) related to BPH patients (over 65 years) in association with catheterization.

Therapeutic Class

BPH/ Urinary retention/ Urinary incontinence

Pharmacology

The symptoms associated with benign prostatic hyperplasia (BPH) such as urinary frequency, nocturia, weak stream, hesitancy and incomplete emptying are related to two components, anatomical (static) and functional (dynamic). The static component is related to the prostate size. But prostate size alone does not correlate with symptom severity. The dynamic component is a function of the smooth muscle tone in the prostate and its capsule, the bladder neck and the bladder base as well as the prostatic urethra. The smooth muscle tone is regulated by alpha-adrenergic receptors. Alfuzosin is an orally active quinazoline derivative, peripherally acting antagonist, exhibits selectivity for postsynaptic alpha-1 adrenergic receptors in the lower urinary tract. Blockade of these adrenoceptors can cause smooth muscle in the bladder neck and prostate to relax, resulting in an improvement in urine flow and a reduction in symptoms of BPH.

Dosage & Administration

Benign prostatic hyperplasia: The recommended dose is 10 mg to be taken once daily after a meal. Acute Urinary Retention: In patients 65 years and older, 10 mg daily after a meal to be taken from the first day of catheterisation. The treatment should be administered for 3-4 days, 2-3 days during catheterisation and 1 day after its removal. In this indication no benefit has been established in patients under 65 years of age or if treatment is extended beyond 4 days. Alfuzosin Hydrochloride tablet should be swallowed whole.

Interaction

Alfuzosin may interact with other alpha-blockers, Atenolol, Cimetidine, Diltiazem, Ketoconazole and Ritonavir.

Contradictions

Alfuzosin Hydrochloride tablet is contraindicated for hypersensitivity to Alfuzosin Hydrochloride, history of orthostatic hypotension, combination with other alpha-1 receptor blockers, hepatic insufficiency.

Side Effects

Dizziness, Headache, Fatigue, Vertigo, Malaise, Tachycardia, Palpitation, Nausea, Abdominal pain, Rash, Diarrhea, Postural hypotension, Syncope, Dry mouth.

Pregnancy & Lactation

Due to the type of indication this is not applicable and should not be used by women.

Overdose Effects

In case of overdosage, the patient should be hospitalised, kept in the supine position, and conventional treatment of hypotension should take place. In case of significant hypotension, the appropriate corrective treatment may be a vasoconstrictor that acts directly on vascular muscle fibres.

Precaution & Warnings

The administration of general anesthetics to patients receiving Alfuzosin could cause profound hypotension. It is recommended that the tablets be withdrawn 24 hours before surgery. If symptoms of angina pectoris start or get worse, taking Alfuzosin should be stopped.

Storage Conditions

Store in a cool and dry place, protected from light